Replies to post #149271 on OWC Pharmaceutical Research Corp (OWCP)

[Ping70]

They can't even get phase one started

Read this again:

RAMAT GAN, Israel, Aug. 21, 2018 /PRNewswire/ -- OWC Pharmaceutical Research Corp. (OTCQB: OWCP), a developer of cannabinoid-based therapies targeting a variety of different medical conditions and disorders, today announced that as part of the our preparation for Phase II efficacy study (the "Psoriasis Study") of our cannabinoid-based ointment for the treatment of skin diseases, we have appointed Professor Yuval Ramot as a consultant. ]

Here comes phase II

$OWCP